Morphine Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Morphine clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Deep Versus Moderate Neuromuscular Blocking

Change in Serum Levels of the Estimated Inflammatory CytokinesTotal Dose of IO FentanylPO Morphine+2 more
Menoufia University88 enrolled1 locationNCT07485517
Recruiting
Not Applicable

Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy

Transversalis Fascia Plane BlockIntrathecal Morphine
Tanta University60 enrolled1 locationNCT07201272
Recruiting
Not Applicable

Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia

Postoperative PainPostoperative Pain, AcuteCesarean Section+2 more
University of Ioannina100 enrolled1 locationNCT07023497
Recruiting
Not Applicable

Comparison of the Analgesic Effect of Oliceridine Versus Morphine or Sufentanil for Postoperative Analgesia in Lumbar Surgeries: a Randomized Control Trial

SafetyValidityMorphine+2 more
Anqing Municipal Hospital90 enrolled1 locationNCT06990893
Recruiting
Phase 2

Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal

Chronic PainDrug Dependence of Morphine TypeSymptom, Withdrawal
University of Calgary40 enrolled1 locationNCT04939623
Recruiting
Not Applicable

Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy

UltrasoundIntrathecal MorphineRectus Sheath Block
Ain Shams University80 enrolled1 locationNCT06837506
Recruiting

Intraoperative Administration of Intravenous Morphine in Patients Undergoing Laparoscopic Cholecystectomy

Postoperative PainLaparoscopic CholecystectomyMorphine
Esbjerg Hospital - University Hospital of Southern Denmark300 enrolled1 locationNCT06182111
Recruiting

Analgesic, Sedative and Antibiotic Pharmacokinetics during Extracorporeal Membrane Oxygenation: Understanding altered pharmacokinetics to improve patient outcomes.

Alterations to the pharmacokinetics of broad spectrum antibiotics (ceftriaxone, cefepime, meropenem, gentamicin, ciprofloxacin, ticarcillin-clavulanate, piperacillin-tazobactum, vancomycin, linezolid, caspofungin, fluconazole, voriconazole, oseltamivir/oseltamivir carboxylate) in critically ill patients receiving ECMO.Alterations to the pharmacokinetics of sedative and analgesic drugs and their metabolites (morphine - morphine 3 glucorunide, morphine 6 glucuronide, midazolam - 1 and 4 hydroxy midazolam, fentanyl - norfentanyl, dexmedetiomedine, propofol, thiopentone) in critically ill patients receiving ECMO.
Critical Care Research Group160 enrolled4 locationsACTRN12612000559819